Abstract
Regenerative medicine using stem cells is expected to provide tools for the replacement or repair of damaged tissues, opening up the possibility of treating many diseases that cannot otherwise be effectively treated. To promote the development of and access to regenerative medicine, it is important to take a balance of expedited provision of innovative therapies and appropriate steps to ensure safety and efficacy. While most developed countries have various regulatory frameworks for clinical trials and medical treatments involving stem cells, the Act on the Safety of Regenerative Medicine and the Revised Pharmaceutical Affairs Law have recently been simultaneously passed by the Japanese Diet. According to the former act, these medical technologies are categorized into 3 classes depending on their anticipated potential risk to human health, and the specific procedures falling into each class are determined. In addition, the act enables medical institutions to commission cell processing by business facilities outside the institution (even foreign facilities) that fulfill the requirements set out by the Ministry of Health, Labour and Welfare, with the aim to promote collaboration between academia and industry from an early stage. ...Continue Reading
References
Dec 2, 1996·FEBS Letters·J E CelisH H Rasmussen
Oct 20, 2004·Health & Place·Sarah Dyer
Oct 20, 2006·The New England Journal of Medicine·Dina Gould Halme, David A Kessler
Oct 24, 2007·Fertility and Sterility·Valerie L BakerG David Adamson
Nov 24, 2007·Cell·Kazutoshi TakahashiShinya Yamanaka
Nov 26, 2010·Nature·David Cyranoski
Dec 3, 2010·The New England Journal of Medicine·Margaret A Hamburg
Mar 1, 2013·Nature·David Cyranoski
Oct 22, 2013·JAMA : the Journal of the American Medical Association·UNKNOWN World Medical Association
Citations
Feb 7, 2018·Hepatology Communications·Giuseppe MazzaMassimo Pinzani
Jun 24, 2014·Nature·Paolo Bianco, Douglas Sipp
Jul 20, 2014·Stem Cells Translational Medicine·Ellen G FeigalNatalie Mount
Sep 13, 2016·International Journal of Molecular Sciences·Salazar JonesXiaofeng Jia
Feb 18, 2017·Journal of Tissue Engineering and Regenerative Medicine·Yoji JokuraMasayuki Yamato
Nov 10, 2017·Regenerative Medicine·Sarah Chan
Nov 1, 2016·Therapeutic Innovation & Regulatory Science·Christopher-Paul MilneGabrielle Simmons
Aug 7, 2020·PloS One·Mitsuru MizunoIchiro Sekiya
Oct 21, 2015·Clinical Pharmacology and Therapeutics·Y Fujita, A Kawamoto
May 24, 2016·Stem Cells International·Kulraj Singh BhangraAhad A Rahim
Oct 14, 2016·Clinical Pharmacology and Therapeutics·T TominagaT Kondo
Oct 7, 2017·Clinical Pharmacology and Therapeutics·Delphi G M CoppensJarno Hoekman
Apr 3, 2019·Journal of Tissue Engineering and Regenerative Medicine·Yoshiki Sawa
Sep 30, 2015·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Natalie M MountJohan Hyllner
Dec 19, 2015·Regenerative Medicine·Michelle G J L HabetsAnnelien L Bredenoord
May 8, 2018·Therapeutic Innovation & Regulatory Science·Makoto TanakaKatsura Tsukamoto
Mar 17, 2017·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Yasuko Inokuma
Jan 8, 2020·Tissue Engineering. Part B, Reviews·Caroline Veronique OberweisPatricia Gálvez-Martín
Apr 28, 2018·Journal of Tissue Engineering and Regenerative Medicine·Kazuo YanoMasayuki Yamato
Mar 1, 2019·Acta Obstetricia Et Gynecologica Scandinavica·Suzanna QueckbörnerKristina Gemzell-Danielsson
Jan 21, 2021·Clinical Pharmacology and Therapeutics·Masafumi ShimokawaHiroyuki Arai
Apr 7, 2020·Current Stem Cell Research & Therapy·Jobin JoseAaron M Thomas
Feb 29, 2020·Regenerative Therapy·Edward H NtegeYusuke Shimizu
Mar 31, 2021·Regenerative Medicine·Maki Umemura, Michael Morrison
Jun 6, 2020·Health Policy·Tingting QiuMondher Toumi